title: Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.
authors.affiliation: Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle upon Tyne, UK. Electronic address: quentin.anstee@newcastle.ac.uk.
authors.forename: Quentin M
authors.initials: QM
authors.lastname: Anstee
authors.affiliation: Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle upon Tyne, UK.
authors.forename: Yang-Lin
authors.initials: YL
authors.lastname: Liu
authors.affiliation: Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle upon Tyne, UK.
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Day
authors.affiliation: Northern Institute for Cancer Research, The Medical School, Newcastle University, Newcastle-upon-Tyne, UK.
authors.forename: Helen L
authors.initials: HL
authors.lastname: Reeves
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000235:genetics*; D005260:Female; D006801:Humans; D008049:Lipase / Q000235:genetics*; D008113:Liver Neoplasms / Q000209:etiology* / Q000235:genetics*; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D065626:Non-alcoholic Fatty Liver Disease / Q000150:complications* / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide
chemical_list: D008565:Membrane Proteins; D008049:Lipase